L. rhamnosus may reduce bloatingEffect of Lacticaseibacillus rhamnosus IDCC 3201 on irritable bowel syndrome with constipation: a randomized, double-blind, and placebo-controlled trial.
High relevance to IBS treatment
We focused on how Lacticaseibacillus rhamnosus IDCC 3201 affects bloating in people with irritable bowel syndrome with constipation (IBS-C).
In a randomized, double-blind, placebo-controlled trial involving 30 participants, those taking the probiotic experienced significant improvements.
After 8 weeks, symptoms like abdominal bloating and bowel satisfaction notably improved in the probiotic group compared to those on placebo.
This suggests that RH 3201 may enhance gut health by boosting beneficial bacteria and associated metabolites.
Read More
We examined the effects of agave inulin on gastrointestinal tolerance, particularly focusing on bloating, in a structured study. This research utilized a randomized, double-blind, placebo-controlled crossover trial, involving 29 healthy adults across three periods, each lasting 21 days with one-week breaks in between.
Participants consumed either 5.0 g or 7.5 g of agave inulin, or a placebo, while we surveyed them for gastrointestinal symptoms. Interestingly, we found that while both doses led to slight increases in bloating and other symptoms like flatulence, the overall intensity remained low on a scale of 0 to 12.
For example, bloating and flatulence were reported slightly more frequently with the inulin, but our scores indicated minimal discomfort. Additionally, we noted improvements in bowel movements, with softer stools and more frequent visits to the bathroom, especially at the higher dosage. Remarkably, diarrhea was not more common with inulin consumption compared to the placebo.
Overall, our findings suggest that while agave inulin can cause some bloating, it's not significant enough to deter its use. Instead, it seems to offer potential benefits in terms of digestive health without major gastrointestinal issues.
Read More
Inulin well tolerated in studyDigestive tolerance of inulin-type fructans: a double-blind, placebo-controlled, cross-over, dose-ranging, randomized study in healthy volunteers.
Highly relevant to bloating effects
We engaged in a comprehensive study to compare the digestive tolerance of various inulin-type fructans over a period of two weeks. In this double-blind, placebo-controlled trial, 84 healthy volunteers participated, testing products like Fibrulose F97 and Fibruline Instant at different dosages.
We recorded various digestive symptoms, such as bloating, abdominal pain, and flatulence, using visual analogue scales. While we noted that the three types of inulin did lead to a mild increase in symptoms, particularly with Fibruline Instant at the highest dose of 20 grams per day, the overall changes were not severe.
Importantly, despite some variations, the different inulin treatments were generally well tolerated. The increase in bloating and other symptoms was significant for the highest dose of Fibruline Instant, but not enough to indicate a problematic response. Therefore, we can say that inulin-type fructans are well tolerated by most people, with only mild digestive discomfort reported.
Read More